Literature DB >> 18729387

Glycosylation analysis of IgLON family proteins in rat brain by liquid chromatography and multiple-stage mass spectrometry.

Satsuki Itoh1, Akiko Hachisuka, Nana Kawasaki, Noritaka Hashii, Reiko Teshima, Takao Hayakawa, Toru Kawanishi, Teruhide Yamaguchi.   

Abstract

IgLON family proteins, including limbic-associated membrane protein (LAMP), opioid-binding cell adhesion molecule (OBCAM), neurotrimin, and Kilon, are immunoglobulin (Ig) superfamily cell adhesion molecules. These molecules are composed of three Ig domains and a glycosylphosphatidylinositol (GPI) anchor and contain six or seven potential N-glycosylation sites. Although their glycosylations are supposed to be associated with the development of the central nervous system like other Ig superfamily proteins, they are still unknown because of difficulty in isolating individual proteins with a high degree of homology in performing carbohydrate analysis. In this study, we conducted simultaneous site-specific glycosylation analysis of rat brain IgLON proteins by liquid chromatography and multiple-stage mass spectrometry (LC-MS ( n )). The rat brain GPI-linked proteins were enriched and separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The four proteins were extracted from the gel, and subjected to LC-MS ( n ) after proteinase digestions. A set of glycopeptide MS data, including the mass spectrum, the mass spectrum in the selected ion monitoring mode, and the product ion spectra, was selected from all data based on carbohydrate-related ions in the MS/MS spectrum. The peptide portion and the carbohydrate structure were identified on the basis of peptide-related ion and carbohydrate-related ions, and the accurate mass. The site-specific glycosylations of four proteins were elucidated as follows. N-Glycans near the N-terminal were disialic acid-conjugated complex- and hybrid-type oligosaccharides. The first Ig domains were occupied by Man-5-9. Diverse oligosaccharides, including Lewis a/x-modified glycans, a brain-specific glycan known as BA-2, and Man-5, were found to be attached to the third Ig domain. Three common structures of glycans were found in the GPI moiety of LAMP, OBCAM, and neurotrimin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18729387     DOI: 10.1021/bi8009778

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  IgLON cell adhesion molecules are shed from the cell surface of cortical neurons to promote neuronal growth.

Authors:  Ricardo Sanz; Gino B Ferraro; Alyson E Fournier
Journal:  J Biol Chem       Date:  2014-12-23       Impact factor: 5.157

Review 2.  Emerging roles for the GPI-anchored tumor suppressor OPCML in cancers.

Authors:  Jane Antony; Elisa Zanini; James R Birtley; Hani Gabra; Chiara Recchi
Journal:  Cancer Gene Ther       Date:  2020-06-29       Impact factor: 5.987

3.  Proteomic identification of mammalian cell surface derived glycosylphosphatidylinositol-anchored proteins through selective glycan enrichment.

Authors:  Leslie K Cortes; Saulius Vainauskas; Nan Dai; Colleen M McClung; Manesh Shah; Jack S Benner; Ivan R Corrêa; Nathan C VerBerkmoes; Christopher H Taron
Journal:  Proteomics       Date:  2014-11       Impact factor: 3.984

4.  Spatiotemporal expression of IgLON family members in the developing mouse nervous system.

Authors:  Sydney Fearnley; Reesha Raja; Jean-François Cloutier
Journal:  Sci Rep       Date:  2021-10-01       Impact factor: 4.379

5.  The Role of N-Glycosylation in the Intracellular Trafficking and Functionality of Neuronal Growth Regulator 1.

Authors:  Gyuri Sim; Moonkyung Jeong; Hyunseok Seo; Jangrae Kim; Soojin Lee
Journal:  Cells       Date:  2022-04-06       Impact factor: 6.600

Review 6.  Glycosylphosphatidylinositol-Anchored Immunoglobulin Superfamily Cell Adhesion Molecules and Their Role in Neuronal Development and Synapse Regulation.

Authors:  Rui P A Tan; Iryna Leshchyns'ka; Vladimir Sytnyk
Journal:  Front Mol Neurosci       Date:  2017-11-15       Impact factor: 5.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.